Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Vor Biopharma Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 60
- +2 vs. Q3 2023
- Shares held
- 59.6M
- −235.2K (−0.4%) vs. Q3 2023
- Total value
- $134.1M
- +$7.25M (+5.7%) vs. Q3 2023
- New holders
- 7
- 21 more added
- Sold out
- 5
- 14 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 102 | $893.0M |
| Q1 2026 | 80 | $716.9M |
| Q4 2025 | 55 | $332.0M |
| Q3 2025 | 37 | $183.4M |
| Q2 2025 | 35 | $91.9M |
| Q1 2025 | 46 | $43.2M |
| Q4 2024 | 52 | $67.6M |
| Q3 2024 | 54 | $33.5M |
| Q2 2024 | 71 | $54.5M |
| Q1 2024 | 69 | $139.7M |
| Q4 2023 | 60 | $134.1M |
| Q3 2023 | 59 | $127.7M |
| Q2 2023 | 71 | $187.8M |
| Q1 2023 | 60 | $325.7M |
| Q4 2022 | 58 | $400.3M |
| Q3 2022 | 48 | $125.5M |
| Q2 2022 | 49 | $154.8M |
| Q1 2022 | 58 | $187.9M |
| Q4 2021 | 61 | $362.0M |
| Q3 2021 | 55 | $481.2M |
| Q2 2021 | 51 | $571.2M |
| Q1 2021 | 49 | $1.31B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Vor Biopharma Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 45 | $101 | 0.00% | 00.0% | Unchanged |
| Eagle Bay Advisors LLC | 150 | $338 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 797 | $1.00K | 0.00% | +797 | New |
| Lazard Asset Management LLC | 2,077 | $4.00K | 0.00% | −89−4.1% | Reduced |
| Amalgamated Bank | 3,286 | $7.00K | 0.00% | −378−10.3% | Reduced |
| Ameritas Investment Partners, Inc. | 3,111 | $7.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 3,627 | $8.14K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,315 | $12.0K | 0.00% | −10,366−66.1% | Reduced |
| Citigroup Inc | 5,737 | $12.9K | 0.00% | +5,719+31,772.2% | Added |
| California State Teachers Retirement System | 6,201 | $14.0K | 0.00% | −2,112−25.4% | Reduced |
| Group One Trading, L.P. | 10,000 | $22.5K | 0.00% | +10,000 | New |
| Wexford Capital LP | 10,050 | $22.6K | 0.00% | +10,050 | New |
| United Bank | 10,900 | $24.5K | 0.00% | +10,900 | New |
| Wells Fargo & Company | 11,610 | $26.1K | 0.00% | +2,292+24.6% | Added |
| Grimes & Company, Inc. | 13,656 | $30.7K | 0.00% | −330−2.4% | Reduced |
| Royal Bank of Canada | 14,271 | $32.0K | 0.00% | +7,122+99.6% | Added |
| Voya Investment Management LLC | 15,894 | $35.8K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 16,945 | $38.1K | 0.00% | +16,945 | New |
| Chicago Partners Investment Group LLC | 17,320 | $40.5K | 0.00% | −676−3.8% | Reduced |
| Invesco Ltd. | 18,038 | $40.6K | 0.00% | +3,515+24.2% | Added |
| American International Group, Inc. | 18,727 | $42.1K | 0.00% | −76−0.4% | Reduced |
| Dimensional Fund Advisors LP | 20,486 | $46.1K | 0.00% | −11,206−35.4% | Reduced |
| SG Americas Securities, LLC | 21,296 | $48.0K | 0.00% | +4,038+23.4% | Added |
| New York State Common Retirement Fund | 21,495 | $48.4K | 0.00% | −121−0.6% | Reduced |
| JPMorgan Chase & Co | 24,498 | $55.1K | 0.00% | −809−3.2% | Reduced |
| Bourgeon Capital Management LLC | 29,450 | $66.3K | 0.01% | +2,500+9.3% | Added |
| Citadel Advisors LLC | 30,646 | $69.0K | 0.00% | +29,036+1,803.5% | Added |
| Deutsche Bank AG | 31,835 | $71.6K | 0.00% | +31,835 | New |
| UBS Group AG | 37,933 | $85.3K | 0.00% | +21,573+131.9% | Added |
| Goldman Sachs Group Inc | 38,336 | $86.3K | 0.00% | +12,774+50.0% | Added |
| Rhumbline Advisers | 42,990 | $96.7K | 0.00% | −1,912−4.3% | Reduced |
| LMR Partners LLP | 51,111 | $115.0K | 0.00% | +2,331+4.8% | Added |
| Renaissance Technologies LLC | 51,600 | $116.0K | 0.00% | +15,100+41.4% | Added |
| Barclays PLC | 52,080 | $117.2K | 0.00% | +44,857+621.0% | Added |
| Bank of America Corp | 53,541 | $120.5K | 0.00% | +22,644+73.3% | Added |
| Bollard Group LLC | 55,555 | $125.0K | 0.00% | 00.0% | Unchanged |
| Exchange Traded Concepts, LLC | 60,170 | $135.4K | 0.00% | +15,258+34.0% | Added |
| Susquehanna International Group, LLP | 63,579 | $143.1K | 0.00% | +10,738+20.3% | Added |
| Nuveen Asset Management, LLC | 71,504 | $160.9K | 0.00% | 00.0% | Unchanged |
| Trustees of Columbia University in the City of New York | 91,910 | $206.8K | 0.44% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 103,918 | $233.8K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 108,209 | $243.5K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 162,700 | $366.1K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 172,061 | $387.1K | 0.00% | +95,037+123.4% | Added |
| Ensign Peak Advisors, Inc | 346,087 | $778.7K | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 357,151 | $803.6K | 0.01% | +357,151 | New |
| Northern Trust Corp | 397,221 | $893.7K | 0.00% | +45,780+13.0% | Added |
| State Street Corp | 608,007 | $1.37M | 0.00% | +2,100+0.3% | Added |
| Sarissa Capital Management LP | 618,000 | $1.39M | 0.21% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 794,063 | $1.79M | 0.00% | +37,711+5.0% | Added |
| Johnson & Johnson | 1,074,658 | $2.42M | 0.06% | 00.0% | Unchanged |
| Woodline Partners LP | 1,111,123 | $2.50M | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,743,463 | $3.92M | 0.00% | +27,017+1.6% | Added |
| BlackRock Inc. | 2,251,411 | $5.07M | 0.00% | +144,542+6.9% | Added |
| Artal Group S.A. | 2,347,424 | $5.28M | 0.18% | −340,591−12.7% | Reduced |
| Laurion Capital Management LP | 3,182,889 | $7.16M | 0.26% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 6,361,723 | $14.3M | 3.80% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 6,457,293 | $14.5M | 0.68% | −4,174−0.1% | Reduced |
| FMR LLC | 7,618,948 | $17.1M | 0.00% | −32,228−0.4% | Reduced |
| Ra Capital Management, L.P. | 22,748,880 | $51.2M | 0.80% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −633,848−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −149,690−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −15,693−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −10,221−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −10,009−100.0% | Sold out |
| OUP Management Co., LLC | – | – | – | – | Not filed |